Cigna Group (NYSE:CI) Stock Rating Upgraded by Sanford C. Bernstein

Cigna Group (NYSE:CI) was upgraded by investment analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a note issued to investors on Thursday, MarketBeat.com reports. The brokerage presently has a $358.00 price target on the health services provider’s stock, up from their previous price target of $307.00. Sanford C. Bernstein’s price objective suggests a potential upside of 34.01% from the company’s previous close.

Other analysts have also recently issued reports about the company. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Jefferies Financial Group lifted their price target on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Piper Sandler lowered their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Barclays dropped their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. Finally, Leerink Partners raised their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $333.11.

Cigna Group Stock Up 0.5%

Shares of CI opened at $267.15 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The company has a 50-day simple moving average of $279.60 and a 200-day simple moving average of $282.94. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The firm has a market capitalization of $70.40 billion, a P/E ratio of 12.04, a P/E/G ratio of 0.92 and a beta of 0.27.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the business earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.70% of the company’s stock.

Institutional Trading of Cigna Group

Several large investors have recently added to or reduced their stakes in CI. Brighton Jones LLC boosted its holdings in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares in the last quarter. Sivia Capital Partners LLC increased its holdings in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after purchasing an additional 109 shares in the last quarter. AE Wealth Management LLC increased its holdings in Cigna Group by 3.9% during the 2nd quarter. AE Wealth Management LLC now owns 4,216 shares of the health services provider’s stock valued at $1,394,000 after purchasing an additional 160 shares in the last quarter. Acadian Asset Management LLC raised its position in Cigna Group by 252.7% in the 2nd quarter. Acadian Asset Management LLC now owns 29,181 shares of the health services provider’s stock valued at $9,640,000 after purchasing an additional 20,907 shares during the last quarter. Finally, SBI Securities Co. Ltd. boosted its stake in Cigna Group by 15.1% in the second quarter. SBI Securities Co. Ltd. now owns 458 shares of the health services provider’s stock worth $151,000 after purchasing an additional 60 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Sanford C. Bernstein upgraded Cigna to “outperform” and raised its price target to $358, citing PBM reform as a clearing event and improved outlook for Evernorth — a catalyst for multiple analysts to raise estimates. Bernstein upgrades CVS and Cigna, citing PBM reform as key clearing event
• Positive Sentiment: Zacks notes CI trades below the industry P/E and highlights Evernorth growth, steady earnings beats and buybacks as supports for the investment case — a valuation/earnings combo that helps explain buying interest. Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?
• Neutral Sentiment: A valuation review highlights recent share-price weakness versus the specialty-pharmacy growth narrative — useful context for investors weighing whether current discounts already reflect execution risks. Evaluating Cigna Group (CI) Valuation After Recent Share Price Weakness And Specialty Pharmacy Growth Narrative
• Neutral Sentiment: A head-to-head comparison with CVS frames Cigna as the play for stronger earnings quality and capital discipline, while reminding long-term investors to consider income, stability and valuation differences when choosing exposure. CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?
• Neutral Sentiment: Zacks’ broader industry outlook continues to single out major HMOs (including Cigna) as key players in a sector balancing tech-enabled growth and policy/operational headwinds. Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene
• Negative Sentiment: Barclays and commentators warn that the timing of a CEO change could surprise investors and introduce strategic/operational uncertainty during a critical execution window. Management transition risk may weigh on sentiment until plans are clearer. The Cigna Group (CI) CEO Change Timing May Come As Surprise to Some Investors, According to Barclays
• Negative Sentiment: Industry pieces flag escalating medical costs, nursing shortages and margin pressure as sector-wide risks that could blunt near-term earnings leverage for HMOs, including Cigna. 4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.